Cargando…
Use of Animal Models for Investigating Cardioprotective Roles of SGLT2 Inhibitors
Sodium-glucose co-transporter 2 (SGLT2) inhibitors represent one type of new-generation type 2 diabetes (T2DM) drug treatment. The mechanism of action of an SGLT2 inhibitor (SGLT2i) in treating T2DM depends on lowering blood glucose levels effectively via increasing the glomerular excretion of gluco...
Autores principales: | Al Thani, Najlaa A., Hasan, Maram, Yalcin, Huseyin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615955/ https://www.ncbi.nlm.nih.gov/pubmed/37052784 http://dx.doi.org/10.1007/s12265-023-10379-5 |
Ejemplares similares
-
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
por: Androutsakos, Theodoros, et al.
Publicado: (2022) -
SGLT-2 inhibitors as cardioprotective agents in COVID-19
por: Gupta, Kashish, et al.
Publicado: (2020) -
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
por: Tentolouris, Anastasios, et al.
Publicado: (2019) -
Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors
por: Fender, Anke C., et al.
Publicado: (2023) -
Cardioprotection by SGLT2 Inhibitors—Does It All Come Down to Na(+)?
por: Trum, Maximilian, et al.
Publicado: (2021)